CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 45 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $297,000 | – | 21,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $53,209,000 | 43.12% |
| Ponoi Management, LLC | 1,880,623 | $63,565,000 | 35.32% |
| Column Group LLC | 2,626,631 | $88,780,000 | 12.57% |
| Euclidean Capital LLC | 554,325 | $18,736,000 | 6.08% |
| Chicago Capital Management, LLC | 295,878 | $10,001,000 | 5.60% |
| COMMODORE CAPITAL LP | 440,869 | $14,901,000 | 5.19% |
| Samson Rock Capital LLP | 467,072 | $15,787,000 | 3.11% |
| S. MUOIO & CO. LLC | 105,000 | $3,549,000 | 3.01% |
| Omni Partners US LLC | 1,815,117 | $61,351,000 | 2.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $21,008,000 | 2.68% |